CClinicalTrials.gg
Status unknownNCT03264872Updated Oct 12, 2018

Peer MI for Substance-using Emerging Adults

A Phase 2 interventional study of Peer-Enhanced Motivational Interviewing and Waitlist Control in Substance-Related Disorders, sponsored by University of Illinois at Urbana-Champaign. Status unknown at 1 site in United States. Open to participants aged 18 Years to 29 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-10-12.

Sponsored by University of Illinois at Urbana-Champaign · Phase 2, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 2
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years to 29 Years
Sex
All
01

Study summary

The main purpose of this project is to test whether Peer-Enhanced Motivational Interviewing (PMI) results in superior alcohol and marijuana use outcomes for emerging adults (EAs, ages 18-29) and their peers. Ninety peer dyads (total n = 180, ntarget client = 90, npeer = 90) are randomized to receive either Peer-Enhanced Motivational Interviewing (PMI) or Waitlist Control (WC).

Read the detailed description

This project randomized peer dyads, consisting of one EA (Emerging Adult; 18-29 years old) with a substance use problem (i.e. target client) and one peer, to one of two conditions. In the Peer-Enhanced Motivational Interviewing (PMI) condition, target clients and peers will receive separate one-hour sessions of Motivational Interviewing (MI) , an empirically-supported treatment that helps individuals work through ambivalence about making changes in substance use. MI is thought to work because it is a non-confrontational intervention where a therapist empathetically reviews substance use behaviors, listens empathetically, and reinforces any client statements indicating a desire to change. With the 'peer' of each PMI dyad, the therapist presents peers with data about the extent of the target client's substance use, builds the peer's motivation to help their friend, and teaches the peer communication skills they can use to influence the target client's substance use. In the WC condition, target clients and peers can receive PMI after the study follow-up period. Both target clients and their peers are followed for 12 weeks post-intervention.

The main purpose of this project is to test whether Peer-Enhanced Motivational Interviewing (PMI) results in superior alcohol and marijuana use outcomes for emerging adults (EAs, ages 18-29) and their peers. Ninety peer dyads (total n = 180, ntarget client = 90, npeer = 90) are randomized to receive either Peer-Enhanced Motivational Intervie (PMI) or Waitlist Control (WC).

02

Conditions studied

  • Substance-Related Disorders

Keywords

  • Motivational Interviewing
03

Who can participate

Ages eligible
18 Years to 29 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

For the Target Client

  • Score 5 or higher on the AUDIT-C measure and/or use alcohol or marijuana 13 days or more out of the past 90 days,
  • Have a friend that they are willing to refer to the study to be their 'peer' (support) and that peer agrees to participate,
  • Are able to complete baseline and follow-up assessments and have a valid email,
  • Are willing to be video recorded, and
  • Are fluent in English

For the Peer

  • Have weekly contact with the participating Target Client who referred them,
  • Are will to attend all study procedures (i.e. baseline assessment, intervention, follow up),
  • Are willing to be video record,
  • Are fluent in English

Exclusion criteria

Exclusion Criteria:

For the Target Client

  • Are current students in the lead Investigator's classes,
  • Are seeking residential treatment at the time of the screening call,
  • Are incarcerated or court-ordered to receive treatment at the time of the screening call,
  • Use drugs besides marijuana or alcohol over 45 of the past 90 days.

For the Peer

  • Are current students in the lead Investigator's classes,
  • Are seeking residential treatment at the time of the screening call,
  • Are incarcerated or court-ordered to receive treatment at the time of the screening call,
  • Use drugs besides marijuana or alcohol over 45 of the past 90 days,
  • Are romantic partners of the Target Client
04

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Peer-Enhanced Motivational Interviewing

    Both dyad members, the target client and their peer support person, in this Peer-Enhanced Motivational Interviewing arm will receive separate one-hour Motivational Interviewing (MI) sessions with a trained counselor.

    Behavioral: Peer-Enhanced Motivational Interviewing

  • Other
    Waitlist Control

    Delayed Treatment.

    Other: Waitlist Control

Interventions

  • BehavioralPeer-Enhanced Motivational Interviewing

    Target clients in this Peer-Enhanced Motivational Interviewing arm will receive separate one-hour Motivational Interviewing (MI) sessions, in which the therapist reviews the target clients substance use behaviors in a non-confrontational manner, listens empathetically, and reinforces any client statements indicating a desire the change. In this arm, the therapist also presents the target client's peer with data about the extent of the target client's substance use, builds the peer's motivation to help their friend, and teaches the peer communication sills they can use to influence the target client's substance use behaviors.

  • OtherWaitlist Control

    After the 12 week follow up period, if subjects in the Waitlist Control group desire to receive the Peer-Enhanced Motivational Interviewing intervention, that will be made available to them.

05

What researchers measure

Primary outcomes

  1. GAIN Substance Problem Scale

    a 16-item scale composed of lifetime symptoms of substance abuse, dependence, and substance-induced health and psychological disorders based on the DSM-IV

    Time frame: Baseline and every 2 weeks during 12 week post-intervention period

Secondary outcomes

  1. GAIN Substance Frequency Scale (change)

    The GAIN substance frequency scale (SFS) measures the percent of days of substance use and percent of days of related problems from such substance use. This scale encompasses a large number of classes of substances, found to be ideal for measurement among poly- substance using individuals.

    Time frame: Baseline and every 2 weeks during 12 week post-intervention period

  2. Rutgers Alcohol Problem Index (change)

    a 23-item self-administered screening tool (questionnaire) for assessing adolescent problem drinking. Respondents simply circle the number that corresponds to the number of times they have experienced each problem. Items can also be read aloud by an interviewer to clients with reading difficulties or it can be used as a springboard for a discussion of problems related to the client's alcohol use.

    Time frame: Baseline and every 2 weeks during 12 week post-intervention period

  3. Significant Other Behavior Questionnaire

    An instrument measuring the specific social support in terms of the patient's drinking. Assessments of the significant other's behavior in the presence of the patient drinking is provided by both the patient and significant other.

    Time frame: Baseline and every 2 weeks during 12 week post-intervention period

06

Study locations

1 of 1 sites recruiting
  • School of Social Work
    Urbana, Illinois 61801, United States
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03264872
Lead sponsor
University of Illinois at Urbana-Champaign
Responsible party
Douglas Smith (Associate Professor, School of Social Work, University of Illinois at Urbana-Champaign) — Principal investigator
First posted
Aug 29, 2017
Start date
Mar 8, 2017
Primary completion
Oct 1, 2021 (estimated)
Completion
Oct 31, 2021 (estimated)
Last update
Oct 12, 2018

Study contacts

Douglas C Smith, PhD
Contact
smithdc@illinois.edu
217-333-5308
Catharaine Fairbairn, PhD
Contact
cfairbai@illinois.edu
(217) 333-0631
Douglas C Smith, PhD
principal investigator · University of Illinois Urbana Champaign School of Social Work

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion